177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
医学
紫杉烷
前列腺癌
肿瘤科
雄激素受体
内科学
雄激素剥夺疗法
临床试验
癌症
乳腺癌
作者
Michael J. Morris,Daniel Castellano,Ken Herrmann,Johann S. de Bono,Neal D. Shore,Kim N.,Michael J. Crosby,Josep M. Piulats,Aude Fléchon,Xiao X. Wei,Hakim Mahammedi,Guilhem Roubaud,Hana Študentová,James Nagarajah,Begoña Mellado,Álvaro Montesa-Pino,Euloge Kpamegan,Samson Ghebremariam,Teri Kreisl,Celine Wilke,Katja Lehnhoff,Oliver Sartor,Karim Fizazi